Abstract
Given the potential morbidity of whole brain radiation therapy (WBRT), there has been an increasing trend to defer WBRT and deliver Gamma Knife stereotactic radiosurgery (GKS) to cerebral metastatic lesions. We analyzed our experience delivering GKS to the tumor cavity following surgical resection of brain metastases and compared our results to patients receiving WBRT after surgical resection of a metastatic lesion. We performed a retrospective review of patients undergoing surgical resection of at least one brain metastasis between December 1999 and December 2008. Both univariate and multivariate Cox proportional hazards regression were utilized to analyze the influence of various prognostic factors on survival. Twenty-five patients had a metastatic lesion resected followed by adjuvant GKS to the resection cavity while another 18 had surgical resection followed by WBRT. Aside from a disparity in gender distribution (72% of GKS patients were female while women only constituted 28% of the WBRT group), no significant differences existed between groups. The median survival for patients receiving GKS was 15.00 months as compared to 6.81 months among those receiving WBRT (P = 0.08). Univariate Cox regression analysis identified the number of metastases (HR 1.65, 95% CI 1.07–2.54, P = 0.02) and regional recurrence (RR 5.23, 95% CI 1.78–15.38, P = 0.003) as poor prognostic factors. Multivariate regression analysis showed that regional recurrence (HR 5.17, 95% CI 1.69–15.78, P = 0.004) was again strongly associated with worse survival. Although limited by the retrospective nature of our study and lack of some clinical measures, patients undergoing GKS to the resection cavity had a trend towards longer median survival.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Patchell RA (2003) The management of brain metastases. Cancer Treat Rev 29:533–540
Bradley KA, Mehta MP (2004) Management of brain metastases. Semin Oncol 31:693–701
Cairncross J, Kim J, Posner J (1980) Radiation therapy for brain metastases. Ann Neurol 7:529–541
Kofman S, Garvin J, Nagamani D et al (1957) Treatment of cerebral metastases from breast carcinoma with prednisolone. JAMA 163:1473–1476
Ruderman N, Hall T (1965) Use of glucocorticoids in the palliative treatment of metastatic brain tumors. Cancer 18:298–306
Mathieu D, Kondziolka D, Flickinger J et al (2008) Tumor bed radiosurgery after resection of cerebral metastases. Neurosurgery 62(4):817–824
Soltys S, Adler J, Lipani J et al (2008) Stereotactic radiosurgery of the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys 70(1):187–193
Shaw E, Scott C, Souhami L et al (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG Protocol 90-05. Int J Radiat Oncol Biol 47(2):291–298
Weissman D (1988) Glucocorticoid treatment for brain metastases and epidural spinal cord compression: a review. J Clin Oncol 6:543–551
Diener-West M, Dobbins T, Phillips T, Nelson D (1989) Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916. Int J Radiat Oncol Biol Phys 16:669–673
Borgelt B, Gelber R, Kramer S et al (1980) The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6:1–9
Deangelis LM, Delattre JY, Posner J (1989) Radiation-induced dementia in patients cured of brain metastases. Neurology 39:789–796
Li J, Bentzen S, Renschler M, Mehta M (2007) Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol 25(10):1260–1266
Asai A, Matsutani M, Kohno T et al (1989) Subacute brain atrophy after radiation therapy for malignant brain tumor. Cancer 63:1962–1974
Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483–2491
Kondziolka D, Patel A, Lunsford LD et al (1999) Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45:427–434
Andrews DW, Scott CB, Sperduto PW et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665–1672
Sneed PK, Suh JH, Goetsch SJ et al (2002) A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53:519–526
Hasegawa T, Kondziolka D, Flickinger JC et al (2003) Brain metastases treated with radiosurgery alone: an alternative to whole brain radiotherapy? Neurosurgery 52:1318–1326
Chidel MA, Suh JH, Reddy CA et al (2000) Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases. Int J Radiat Oncol Biol Phys 47:993–999
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hwang, S.W., Abozed, M.M., Hale, A. et al. Adjuvant Gamma Knife radiosurgery following surgical resection of brain metastases: a 9-year retrospective cohort study. J Neurooncol 98, 77–82 (2010). https://doi.org/10.1007/s11060-009-0051-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-009-0051-x